A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
NCT ID: NCT03773965
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
190 participants
INTERVENTIONAL
2019-04-05
2031-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
NCT03773978
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT04088396
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
NCT04088409
A Moderate to Severe Rheumatoid Arthritis Study
NCT01721044
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
NCT01711359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baricitinib
Baricitinib given orally.
Baricitinib
Administered orally.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baricitinib
Administered orally.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Participants must have not developed an allergy to baricitinib.
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST
Role: STUDY_DIRECTOR
Eli Lilly and Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto CAICI SRL
Rosario, , Argentina
Centro de Investigaciones Médicas Tucuman
SAN M. de Tucuman, , Argentina
Royal Children's Hospital
Melbourne, , Australia
Perth Children's Hospital
Perth, , Australia
The Children's Hospital at Westmead
Westmead, , Australia
Landeskrankenhaus Bregenz
Bregenz, , Austria
Cliniques universitaires Saint-Luc
Brussels, , Belgium
UZ Gent
Ghent, , Belgium
UZ Leuven
Leuven, , Belgium
Faculdade de Medicina da UNESP
Botucatu, , Brazil
Hospital de Clinicas de Porto Alegre
Porto Alegre, , Brazil
IPITEC
São Paulo, , Brazil
Universidade Federal de Sao Paulo
São Paulo, , Brazil
Instituto da Crianca do Hospital das Clinicas da FMUSP
São Paulo, , Brazil
Beijing Children's hospital, Capital Medical University
Beijing, , China
The Children's Hospital of Chongqing Medical University
Chongqing, , China
Childrens Hospital of Nanjing Medical University
Nanjing, , China
Children's Hospital of Soochow University
Suzhou, , China
Detska nemocnice FN Brno
Brno, , Czechia
Fakultni nemocnice Olomouc
Olomouc, , Czechia
Vseobecna fakultni nemocnice v Praze
Prague, , Czechia
Fakultni nemocnice Motol
Prague, , Czechia
Aarhus Universitetshospital, Skejby
Aarhus, , Denmark
Hospices Civils de Lyon - Hôpital Femme Mère Enfant
Bron, , France
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre
Le Kremlin-Bicêtre, , France
Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Hôpital Universitaire Necker Enfants Malades
Paris, , France
Centre Hospitalier Universitaire de Poitiers
Poitiers, , France
Helios Klinikum Berlin-Buch
Berlin, , Germany
Charité Campus Virchow-Klinikum
Berlin, , Germany
Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari
Hamburg, , Germany
Universitätsklinikum Heidelberg
Heidelberg, , Germany
Asklepios Klinik Sankt Augustin
Sankt Augustin, , Germany
Universitaetsklinikum Tuebingen
Tübingen, , Germany
Sri Ramachandra MedicaL College & Research Institute
Chennai, , India
Sir Ganga Ram Hospital
New Delhi, , India
Christian Medical College Vellore
Vellore, , India
Rambam Health Care Campus
Haifa, , Israel
Meir Medical Center
Kfar Saba, , Israel
Schneider Children's Medical Center
Petah Tikva, , Israel
Sheba Medical Center
Ramat Gan, , Israel
Azienda Ospedaliera Spedali Civili di Brescia
Brescia, , Italy
Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti
Chieti, , Italy
IRCCS Istituto Giannina Gaslini
Genova, , Italy
Centro Specialistico Ortopedico Traumatologico Gaetano Pini - CTO
Milan, , Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, , Italy
University of Naples Federico II
Napoli, , Italy
Azienda di Rilievo Nazionale e Alta Specializzazione Civico Di Cristina Benfratelli
Palermo, , Italy
Ospedale Infantile Burlo Garofolo
Trieste, , Italy
Institute of Science Tokyo Hospital
Bunkyō, , Japan
Chiba Children's Hospital
Chiba, , Japan
Kagoshima University Hospital
Kagoshima, , Japan
Kanazawa University Hospital
Kanazawa, , Japan
Niigata University Medical & Dental Hospital
Niigata, , Japan
Saitama Children's Medical Center
Saitama-shi, , Japan
Miyagi Children's Hospital
Sendai, , Japan
Tokyo Women's Medical University Hospital
Shinjuku-ku, , Japan
Osaka Medical and Pharmaceutical University Hospital
Takatsuki, , Japan
Kanagawa Children's Medical Center
Yokohama, , Japan
Yokohama City University Hospital
Yokohama, , Japan
Investigacion y Biomedicina de Chihuahua
Chihuahua City, , Mexico
Instituto de Investigaciones Clínicas para la Salud
Durango, , Mexico
Crea de Guadalajara
Guadalajara, , Mexico
Clinstile, S.A. de C.V.
México, , Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, , Mexico
Wojewódzki Specjalistyczny Szpital Dziecięcy im. św. Ludwika w Krakowie
Krakow, , Poland
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
Lodz, , Poland
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji
Warsaw, , Poland
Federal State Budgetary Scientific Institution Research Institute Rheumatology named after V.A.Nasonova
Moscow, , Russia
Scientific Center of Children's Health
Moscow, , Russia
Hospital Sant Joan de Déu
Esplugues de Llobregat, , Spain
Hospital Infantil Universitario Niño Jesús
Madrid, , Spain
Hospital Universitario Ramón y Cajal
Madrid, , Spain
Hospital Universitario La Paz
Madrid, , Spain
Hospital Universitario Virgen Del Rocio
Seville, , Spain
Hospital Universitari i Politecnic La Fe
Valencia, , Spain
Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine
Istanbul, , Turkey (Türkiye)
9 Eylul University Hospital
Izmir, , Turkey (Türkiye)
Bristol Royal Hospital for Children
Bristol, , United Kingdom
Alder Hey Children's Hospital
Liverpool, , United Kingdom
Great Ormond Street Hospital For Children NHS Foundation Trust
London, , United Kingdom
Oxford University Hospitals - Nuffield Orthopaedic Centre
Oxford, , United Kingdom
Sheffield Children's Hospital
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role: CONTACT
Physicians interested in becoming principal investigators please contact
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I4V-MC-JAHX
Identifier Type: OTHER
Identifier Source: secondary_id
2017-004471-31
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
16278
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.